spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Esophageal Cancer 

 HSMN NewsFeed - 9 Jun 2023
Astellas Submits New Drug Application for Zolbetuximab in Japan
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 13 Jul 2022
Mauna Kea Technologies Announces Publication of a Meta-Analysis Demonstrating Cellvizio’s Significant Role in Detection of Esophageal Dysplasia and Cancer
Devices Diagnostics Oncology
 HSMN NewsFeed - 28 Dec 2020
Elevar Therapeutics Announces Licensing Agreement with Inceptua Group for Commercialization of Apealea(R) (Paclitaxel Micellar) in Europe
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 23 Dec 2020
Rakuten Medical Enrolls First Patient in the U.S. Clinical Trial for its Lead Product, ASP-1929 in Combination with Anti-PD1 Therapy, for Head and Neck Cancer or Cutaneous Squamous Cell Carcinoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Jul 2020
CARISMA Therapeutics Announces FDA Clearance of IND Application for First-Ever Engineered Macrophage Immunotherapy
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 26 May 2020
Elevar Therapeutics Appoints Mark Gelder, M.D. as Global Head of Medical Affairs
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 25 Mar 2020
Elevar Therapeutics Acquires Global Rights to European Approved Apealea(R) from Oasmia Pharmaceutical
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 26 Dec 2019
OBI Pharma Granted FDA Orphan Drug Designation for the Treatment of Pancreatic Cancer for Its Antibody-Drug Conjugate (ADC) Targeted Cancer Therapy, OBI-999
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 11 Nov 2019
AI Medical Service Inc. announces FDA Breakthrough Device Designation for endoscopic AI system
Devices Gastroenterology FDA
 HSMN NewsFeed - 12 Aug 2019
Oncologie, Inc. Announces Clinical Trial Collaboration With Merck to Evaluate Bavituximab in Combination With KEYTRUDA(R) (Pembrolizumab) in Advanced Gastric or Gastroesophageal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Oct 2018
CSA Medical Secures $23 Million to Advance its Cryospray(TM) Therapies for Esophageal Disease and COPD
Devices Venture Capital
 HSMN NewsFeed - 20 Jun 2018
Steba Biotech's TOOKAD(R) Vascular Photodynamic Therapy Maintains Significant Reduction in Overall Progression and Conversion to Radical Therapy in Low-risk Prostate Cancer Patients at 4 Years
Biopharmaceuticals Urology Oncology
 HSMN NewsFeed - 1 Jun 2018
PENTAX Medical Introduces Next-Generation C2 CryoBalloon(TM) Ablation System for Treatment of Barrett's Esophagus
Devices Gastroenterology Product Launch
 HSMN NewsFeed - 10 May 2018
Interpace Diagnostics Announces Expanded Coverage Among Blue Cross Blue Shield Plans
Diagnostics Oncology Reimbursement
 HSMN NewsFeed - 21 Mar 2018
Cernostics Raises $2.5 Million in Series A1 Financing, Led by Illumina Ventures
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 6 Feb 2018
New Study Finds truFreeze(R) Spray Cryotherapy Less Painful than Radiofrequency Ablation for Treatment of Barrett's Esophagus Related Diseases
Devices Gastroenterology
 HSMN NewsFeed - 12 Sep 2017
Cernostics Announces Leadership Team Expansion
Diagnostics Oncology Personnel
 HSMN NewsFeed - 7 Aug 2017
Biostage Announces the Use of Its Esophageal Implant Product Candidate in a Patient
Devices Regenerative Medicine
 HSMN NewsFeed - 13 Jul 2017
American Society for Radiation Oncology Updates Insurance Coverage Recommendations for Proton Therapy
Devices Oncology
 HSMN NewsFeed - 16 Mar 2017
Biostage Promotes Saverio La Francesca, M.D. to President
Devices Regenerative Medicine Personnel
 HSMN NewsFeed - 10 Jan 2017
PENTAX Medical Expands Interventional Endoscopy Offering with Acquisition of C2 Therapeutics
Devices Mergers & Acquisitions
 HSMN NewsFeed - 2 Dec 2016
CSA Medical Announces First Use of Significantly Reduced Diameter Cryogen Decompression Tube in a truFreeze(R) Spray Cryotherapy Case
Devices Product Launch
 HSMN NewsFeed - 25 Nov 2016
Macrocure Announces New Date for Special General Meeting of Shareholders to Approve Merger With Leap Therapeutics
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 18 Nov 2016
Athenex and Lilly Enter Clinical Collaboration Agreement
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Nov 2016
Boston Scientific Announces Acquisition Of The LumenR(TM) Tissue Retractor System
Devices Surgery Acquisitions
 HSMN NewsFeed - 28 Oct 2016
Astellas to Acquire Ganymed Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 Aug 2016
Leap Therapeutics and Macrocure Announce Definitive Merger Agreement
Biopharmaceuticals Wound Care Mergers & Acquisitions
 HSMN NewsFeed - 29 Jun 2016
Biostage Files for FDA Orphan Drug Designation for Cellspan(TM) Esophageal Implant
Regenerative Medicine FDA
 HSMN NewsFeed - 24 Jun 2016
Medigus’ MUSE(TM) Continues to Gain Clinical Adoption in the U.S.
Devices Surgery Gastroenterology
 HSMN NewsFeed - 25 Jan 2016
Steba Biotech Completes its European Phase 3 Clinical Trial of TOOKAD(R) in Patients with Low-Risk Prostate Cancer and Submits Marketing Authorization Application to the European Medicine Agency
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 3 Nov 2015
Castle Biosciences Announces the Appointment of Federico Monzon, M.D., FCAP as Chief Medical Officer
Diagnostics Oncology Personnel
 HSMN NewsFeed - 20 Oct 2015
EndoStim receives CE Mark for full body MRI use with EndoStim II LES Stimulation System
Devices Gastroenterology Regulatory
 HSMN NewsFeed - 25 Sep 2015
Merck and Pfizer Announce FDA Orphan Drug Designation for Investigational Immunotherapy Avelumab in Merkel Cell Carcinoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 29 Jul 2015
C2 Therapeutics Receives FDA 510(k) Clearance for the Coldplay Cryoballoon(TM) Full and Swipe Ablation Systems
Devices Gastroenterology FDA
 HSMN NewsFeed - 27 Jul 2015
Castle Biosciences Closes $11.7 Million Tranche of $20 Million Financing
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 7 Oct 2014
Pinnacle Biologics, Inc., a subsidiary of Concordia Healthcare Corp., announces European site initiation of Phase 3 bile duct cancer trial using photodynamic therapy with PHOTOFRIN(R)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Sep 2014
New Study Shows Magnetic Implant is an Important Break-Through in the Treatment of Reflux Disease
Devices Gastroenterology
 HSMN NewsFeed - 13 Aug 2014
Castle Biosciences Announces $11.8 Million Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 25 Jul 2014
Guided Therapeutics Files PMA Amendment with FDA for LuViva(R) Advanced Cervical Scan
Devices Diagnostics FDA
 HSMN NewsFeed - 2 Apr 2014
Landmark Publication Affirms Safety of LINX(R), a New Treatment Option for Gastroesophageal Reflux Disease
Devices Gastroenterology
 HSMN NewsFeed - 26 Mar 2014
FDA Approves Optiguide(R) DCYL700 Fiber Optic Diffuser Series Flexible Fiber
Devices FDA
 HSMN NewsFeed - 7 Jan 2014
Guided Therapeutics Names Gene Cartwright as Chief Executive Officer
Devices Diagnostics Oncology Personnel
 HSMN NewsFeed - 24 Dec 2013
Concordia Healthcare Corp. Announces Acquisition Of Pinnacle Biologics, Inc.
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 22 May 2013
Covidien Announces Clinical Trial Data Showing Endoscopic Ablation Therapy Eliminates Precancerous Esophageal Tissue and Significantly Reduces Disease Progression
Devices Gastroenterology
 HSMN NewsFeed - 6 Feb 2013
Guided Therapeutics to Develop Esophageal Cancer Product; Acquires Intellectual Property Rights from Konica Minolta
Devices Oncology Acquisitions
 HSMN NewsFeed - 2 Oct 2012
Cell Therapeutics OPAXIOTM Receives Orphan Drug Designation for Malignant Brain Cancer from FDA
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Sep 2012
Torax Medical Secures $30M Financing to Commercialize Pioneering Treatment for Reflux Disease
Devices Gastroenterology Venture Capital
 HSMN NewsFeed - 27 Mar 2012
FDA Approves LINX(R) System for the Treatment of Reflux Disease
Devices Gastroenterology FDA
 HSMN NewsFeed - 21 Nov 2011
BARRX Medical, Inc. Announces Definitive Agreement to be Acquired by Covidien
Devices Mergers & Acquisitions
 HSMN NewsFeed - 21 Nov 2011
Covidien Announces Definitive Agreement to Acquire BÂRRX Medical, Inc.
Devices Mergers & Acquisitions
 HSMN NewsFeed - 20 Jan 2011
BSD Medical Reports Publication of German Oncology Journal Der Onkologe Emphasizing Benefits of Hyperthermia in Treatment of Cancer
Devices Oncology
 HSMN NewsFeed - 7 Oct 2010
Spectral Molecular Imaging, Inc. Introduces Its Early Melanoma Detection Device SkinSpect(TM)
Devices Oncology
 HSMN NewsFeed - 7 Sep 2010
BARRX Medical Signs Distribution Agreement With Medico's Hirata for Exclusive Distribution of the HALO Radiofrequency Ablation System in Japan
Devices Gastroenterology Distribution
 HSMN NewsFeed - 26 Aug 2010
Spectral Molecular Imaging, Inc. Announces Accelerated Timeline for its Early Melanoma Detection Product, SkinSpect
Devices Dermatology Oncology
 HSMN NewsFeed - 14 Jul 2010
BARRX Medical, Inc. Completes $15 Million Growth Financing
Devices Gastroenterology Venture Capital
 HSMN NewsFeed - 28 Apr 2010
Konica Minolta Opto, Inc. Extends Product Development Licensing Agreement with Guided Therapeutics
Devices Diagnostics Oncology Licensing
 HSMN NewsFeed - 7 Apr 2010
Torax Medical Receives CE Mark for Its LINX(R) Anti-Reflux Treatment
Devices Gastroenterology Regulatory
 HSMN NewsFeed - 2 Feb 2010
Guided Therapeutics, Inc. Receives New Funding Commitment from Konica Minolta Opto, Inc. to Expand Cancer Detection Product Line
Devices Diagnostics Oncology
 HSMN NewsFeed - 20 Nov 2009
Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent
Devices Interventional Gastroenterology FDA
 HSMN NewsFeed - 1 Jun 2009
Study Concludes PillCam ESO(R) Correlates Well With EGD in Detecting and Grading Esophageal Varices -- A Potentially Lethal Complication of Advanced Liver Disease
Devices Gastroenterology
 HSMN NewsFeed - 29 May 2009
New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 Jul 2008
Sweden to Receive Scandinavia's First TomoTherapy System
Devices Oncology
 HSMN NewsFeed - 21 Jul 2008
Precancerous Esophagus Disease Eliminated in 98.4% of Patients Treated With HALO Ablation System
Devices Gastroenterology
 HSMN NewsFeed - 9 Jun 2008
Cook Medical Announces FDA 510(k) Clearance of Evolution(R) Controlled Release Esophageal Stent System
Devices Interventional Oncology FDA
 HSMN NewsFeed - 20 May 2008
Early Esophageal Cancer and Pre-Cancer Eliminated With Non-Surgical Treatment Combination
Devices Gastroenterology Oncology
 HSMN NewsFeed - 19 May 2008
Presentation of Landmark Clinical Trial Evaluating Endoscopic Treatment for Pre-cancerous Condition of Esophagus
Devices Gastroenterology
 HSMN NewsFeed - 15 May 2008
New Study Reports That Ablative Therapy With HALO360 Device Effectively Treats Highest-Risk Category of Barrett's Esophagus
Devices Gastroenterology
 HSMN NewsFeed - 6 Mar 2008
New Clinical Studies Presented at the 14th World Congress of Anesthesiology Demonstrate Masimo Advancements in Patient Care
Devices Monitoring
 HSMN NewsFeed - 25 Jan 2008
Over 30 New Studies of Oral Xeloda(R) Featured at the 2008 Gastrointestinal Cancers Symposium
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Jan 2008
Xeloda(R) Combination Therapy in Esophagogastric Cancer Highlighted in New England Journal of Medicine
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Nov 2007
Given Imaging Announces Aetna to Cover Capsule Endoscopy of the Esophagus
Devices Gastroenterology Reimbursement
 HSMN NewsFeed - 8 Nov 2007
SpectraScience Acquires Luma Imaging Corporation
Devices Radiology Mergers & Acquisitions
 HSMN NewsFeed - 11 Oct 2007
Given Imaging Announces National Government Services Expands Policy to Cover Capsule Endoscopy of the Esophagus
Devices Gastroenterology Reimbursement
 HSMN NewsFeed - 10 Oct 2007
SpectraScience Receives Final European Certification
Diagnostics Regulatory
 HSMN NewsFeed - 25 Sep 2007
SpectraScience Appoints the Honorable Tommy Thompson to its Board of Directors
Devices Gastroenterology Oncology Personnel
 HSMN NewsFeed - 16 Aug 2007
SpectraScience Appoints Michel Vaudry as Director of International Sales
Devices
 HSMN NewsFeed - 18 Jun 2007
SpectraScience Appoints John Pappajohn to Board of Directors
Devices Personnel
 HSMN NewsFeed - 4 Jun 2007
YM BioSciences Cleared to Initiate Clinical trial of Nimotuzumab in Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 May 2007
NCCN Updates Esophageal and Gastric Cancer Guidelines
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 May 2007
Presentation of Long-term Results for Treating Barrett's Esophagus with HALO Ablation System
Devices Gastroenterology
 HSMN NewsFeed - 17 May 2007
DUSA Pharmaceuticals Receives Orphan Drug Designation for Levulan(R) PDT to Treat Esophageal Dysplasia
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 May 2007
Genetic Abnormalities Associated With Esophageal Cancer Eliminated After Treatment With HALO Ablation System
Devices Gastroenterology
 HSMN NewsFeed - 16 Apr 2007
YM BioSciences' partner Daiichi Sankyo receives clearance for initial clinical trial in Japan
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 9 Apr 2007
SpectraScience Hires Director of Sales and Marketing
Diagnostics Personnel
 HSMN NewsFeed - 1 Mar 2007
Point Therapeutics Provides Clinical Update
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Feb 2007
Aspirin Significantly Reduces Esophageal-Cancer Risk in People With Most- Aggressive Form of Barrett's Esophagus
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Feb 2007
Study Reports 70% of Barrett's Esophagus Patients Cured at One-Year Follow-Up in Multi-Center Study
Devices
 HSMN NewsFeed - 30 Jan 2007
YM BioSciences announces termination of the tesmilifene Phase III pivotal trial in advanced breast cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 Oct 2006
Prominent Oncologist, Dr. David Sidransky, Joins Zila Board
Diagnostics Personnel
 HSMN NewsFeed - 20 Jul 2006
YM BioSciences reports anti-EGFr drug nimotuzumab approved in India for treatment of head and neck cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 23 May 2006
Long-Term Results from TNFerade(TM) Pancreatic Cancer Study and Updated Survival Results from TNFerade(TM) Esophageal Cancer Study Both Reported at Digestive Disease Week
Biopharmaceuticals Oncology
Return to NewsFeed  

 Additional items found! 46

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 46 additional stories matching:
Esophageal Cancer
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.